FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to a method for producing magnetic liposomes. Method of producing magnetic liposomes involves preparing a suspension comprising phosphatidylcholine and magnetic nanoparticles, treating it with ultrasound and repeating its freezing-thawing procedure, magnetic nanoparticles used are magnetite nanoparticles in the form of an aqueous sol, where the repeated freezing-thawing procedure involves freezing said suspension at a temperature of liquid nitrogen, its subsequent smooth thawing at room temperature and additionally includes its further ultrasonic treatment with power of 70 W and frequency of 40 kHz at temperature of 20–30 °C for 5–15 minutes, wherein said procedure is repeated at least three times.
EFFECT: disclosed method is effective for obtaining optimum liposomes of magnetic liposomes.
12 cl, 2 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING MAGNETOSENSITIVE LIPOSOMES | 2007 |
|
RU2357724C1 |
LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
LIPOSOMAL PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING IT | 2007 |
|
RU2494729C2 |
COMPOSITION FOR DRUG SUBSTANCE INTEGRATION INTO LIPID MATRIX, DRUG COMPOSITION WITH PHOSPHOLIPID FATTY ACID SYSTEM AND METHOD FOR PREPARING THEM | 2011 |
|
RU2463056C1 |
METHOD OF PRODUCING LIPOSOMAL FORM OF BETULIN, HAVING HEPATOPROTECTIVE ACTIVITY | 2019 |
|
RU2740553C2 |
AGENT IMPROVING ANTI-CANCER EFFECT AND CONTAINING LIPOSOMAL AGENT CONTAINING OXALIPLATIN, AND ANTI-CANCER AGENT CONTAINING LIPOSOMAL AGENT | 2009 |
|
RU2492863C2 |
LIPOSOMAL COMPOSITION | 2010 |
|
RU2476216C1 |
METHOD OF TREATING ONCOLOGICAL DISEASES BY DRUG INJECTIONS | 2018 |
|
RU2706427C1 |
MEDIUM OF CRYOPRESERVATION OF BULL SEMEN AND METHOD OF ITS PREPARATION | 2014 |
|
RU2577882C1 |
Authors
Dates
2019-08-20—Published
2018-08-23—Filed